EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Chronic Kidney Disease and Risk of Mortality and Major Adverse Limb Events After Femoral Artery Endovascular Revascularization for Peripheral Artery Disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) Study

Peter Evans iD, Piotr Sobieszczyk, Andrew C Eisenhauer, Thomas M Todoran, Scott Kinlay iD

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.31447 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Peter Evans und 4 weiteren Autor:innen. Beteiligte Einrichtung: Boston University Medical Center, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Renal Insufficiency, Chronic, Femoral Artery, Endovascular Procedures. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CSRD VA, This study was supported by a VA Clinical Science Research and Development Award 1/01CX001549..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic kidney disease (CKD) is associated with worse outcomes in peripheral artery disease (PAD). The impact of the severity of CKD on mortality and major adverse limb events (MALE) after endovascular revascularization of the superficial femoral artery (SFA) is unknown.

Aims

To assess the relationship of increasing severity of CKD on the risk of mortality and MALE in patients after endovascular revascularization of the SFA.

Methods

We followed a cohort of 202 patients (253 limbs) with SFA endovascular revascularization for claudication or chronic limb‐threatening ischemia in two academic centers between 2003 and 2011. Patients were categorized into four Kidney Disease Improving Global Outcomes (KDIGO) categories of increasingly worse CKD based on estimated glomerular filtration rate (eGFR). The primary outcome was all‐cause death. Secondary outcomes included cardiovascular death, noncardiovascular death, and MALE. The relationship between CKD severity and outcomes was assessed by hazard ratios (HR) and 95% confidence intervals (95%CI) from cause‐specific multivariable Cox proportional hazards models and Fine‐Gray competing risks analyses.

Results

During a median follow‐up of 9.3 years, there was a graded and increasing risk of all‐cause, cardiovascular, and noncardiovascular mortality with worse eGFR (all tests of trend p < 0.001). The lowest eGFR category (< 45 mL/min/1.73 m²) was associated with the highest risk of all‐cause mortality (HR = 5.0, 95% CI = 2.4, 10), cardiovascular mortality (HR = 5.8, 95% CI = 1.8, 18), and noncardiovascular mortality (HR = 4.5, 95% CI = 1.9, 11). There was no significant association between CKD severity and MALE or minor revascularization events.

Conclusion

The risk of mortality risk after SFA endovascular revascularization incrementally increases with decreasing renal function. However, impaired renal function is not related to the risk of adverse limb events and supports femoral revascularization in these patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peripheral Arterial DiseaseRenal Insufficiency, ChronicFemoral ArteryEndovascular ProceduresIschemiaKidneyIntermittent ClaudicationHumansMaleAgedFemaleRisk FactorsTreatment OutcomeTime FactorsRisk AssessmentGlomerular Filtration RateMiddle AgedSeverity of Illness IndexBostonAged, 80 and overSex FactorsRetrospective StudiesChronic Limb-Threatening Ischemia

Stichwörter der Autor:innen

CKDPADadverse limb eventsendovascular revascularization

Autor:innen und Institutionen

  • Boston University Medical Center, Boston, Massachusetts, USA.
  • Veterans Affairs Boston Healthcare System, West Roxbury, Massachusetts, USA.
  • Boston University School of Medicine, Boston, Massachusetts, USA.
  • Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Previously Brigham and Women's Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Peter Evans, Scott Kinlay

Förderung

  • CSRD VA
  • This study was supported by a VA Clinical Science Research and Development Award 1/01CX001549.

Zitieren

APA

Evans, P., Sobieszczyk, P., Eisenhauer, A. C., Todoran, T. M., & Kinlay, S. (2025). Chronic Kidney Disease and Risk of Mortality and Major Adverse Limb Events After Femoral Artery Endovascular Revascularization for Peripheral Artery Disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) Study. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31447

Vancouver

Evans P, Sobieszczyk P, Eisenhauer AC, Todoran TM, Kinlay S. Chronic Kidney Disease and Risk of Mortality and Major Adverse Limb Events After Femoral Artery Endovascular Revascularization for Peripheral Artery Disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) Study. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.31447

BibTeX
@article{Evans2025,
  author = {Evans, Peter and Sobieszczyk, Piotr and Eisenhauer, Andrew C and Todoran, Thomas M and Kinlay, Scott},
  title = {Chronic Kidney Disease and Risk of Mortality and Major Adverse Limb Events After Femoral Artery Endovascular Revascularization for Peripheral Artery Disease: The Boston Femoral Artery Endovascular Revascularization Outcomes (Boston FAROUT) Study},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.31447}
}
Kostenlos starten →